BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

842 related articles for article (PubMed ID: 35247287)

  • 1. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of emergency Cesarean delivery in pregnancies complicated by placenta previa with or without placenta accreta spectrum disorder: analysis of ADoPAD cohort.
    ADoPAD (Antenatal Diagnosis of Placental Attachment Disorders) Study Group
    Ultrasound Obstet Gynecol; 2024 Feb; 63(2):243-250. PubMed ID: 37698306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of preoperative ultrasound signs associated with bladder injury during complex Cesarean delivery: case-control study.
    Hussein AM; Thabet MM; Elbarmelgy RA; Elbarmelgy RM; Jauniaux E
    Ultrasound Obstet Gynecol; 2024 Jun; 63(6):781-788. PubMed ID: 38243910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery.
    Coutinho CM; Giorgione V; Noel L; Liu B; Chandraharan E; Pryce J; Frick AP; Thilaganathan B; Bhide A
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):91-96. PubMed ID: 32865834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the utero-placental circulation in cesarean scar pregnancies: a case-control study.
    Jauniaux E; Zosmer N; De Braud LV; Ashoor G; Ross J; Jurkovic D
    Am J Obstet Gynecol; 2022 Mar; 226(3):399.e1-399.e10. PubMed ID: 34492222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interobserver agreement in MRI assessment of severity of placenta accreta spectrum disorders.
    Finazzo F; D'antonio F; Masselli G; Forlani F; Palacios-Jaraquemada J; Minneci G; Gambarini S; Timor-Tritsch I; Prefumo F; Buca D; Liberati M; Khalil A; Cali G
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):467-473. PubMed ID: 31237043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester ultrasound diagnostic features of placenta accreta spectrum in low-implantation pregnancy.
    Abinader RR; Macdisi N; El Moudden I; Abuhamad A
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):457-464. PubMed ID: 34837427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of transvaginal ultrasound in the third-trimester evaluation of patients at high risk of placenta accreta spectrum at birth.
    Jauniaux E; Hussein AM; Thabet MM; Elbarmelgy RM; Elbarmelgy RA; Jurkovic D
    Am J Obstet Gynecol; 2023 Oct; 229(4):445.e1-445.e11. PubMed ID: 37187303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracervical lakes as sonographic marker of placenta accreta spectrum disorder in patients with placenta previa or low-lying placenta.
    di Pasquo E; Ghi T; Calì G; D'Antonio F; Fratelli N; Forlani F; Prefumo F; Kaihura CT; Volpe N; Dall'Asta A; Frusca T
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):460-466. PubMed ID: 31503353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome.
    Calí G; Timor-Tritsch IE; Forlani F; Palacios-Jaraquemada J; Monteagudo A; Kaelin Agten A; Flacco ME; Khalil A; Buca D; Manzoli L; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):450-459. PubMed ID: 31788885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders.
    Cavalli C; Maggi C; Gambarini S; Fichera A; Santoro A; Grazioli L; Prefumo F; Odicino FE; Fratelli N
    J Perinat Med; 2022 Mar; 50(3):277-285. PubMed ID: 34854274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up ultrasound in second-trimester low-positioned anterior and posterior placentae: prospective cohort study.
    Jansen CHJR; Kleinrouweler CE; Kastelein AW; Ruiter L; van Leeuwen E; Mol BW; Pajkrt E
    Ultrasound Obstet Gynecol; 2020 Nov; 56(5):725-731. PubMed ID: 31671480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Delphi study of ultrasound signs associated with placenta accreta spectrum.
    Jauniaux E; D'Antonio F; Bhide A; Prefumo F; Silver RM; Hussein AM; Shainker SA; Chantraine F; Alfirevic Z;
    Ultrasound Obstet Gynecol; 2023 Apr; 61(4):518-525. PubMed ID: 36609827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower uterine segment scar assessment at 11-14 weeks' gestation to screen for placenta accreta spectrum in women with prior Cesarean delivery.
    Bhatia A; Palacio M; Wright AM; Yeo GSH
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):40-48. PubMed ID: 34254386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of ultrasound features of placenta accreta spectrum in women at high risk: association with outcome and interobserver concordance.
    Bhide A; Hussein AM; Elbarmelgy RM; Elbarmelgy RA; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2023 Jul; 62(1):137-142. PubMed ID: 36882604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis.
    Jauniaux E; Bhide A
    Am J Obstet Gynecol; 2017 Jul; 217(1):27-36. PubMed ID: 28268196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].
    Bai GQ; Chen WL; Huang XH; Zhao SJ; Zhao SP; Chen XJ; Chen SW; Yang H; Lu X; Liu GY; Chen QH; Zhang LA; Jin L
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):26-36. PubMed ID: 36720612
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of classic and novel ultrasound signs of placenta accreta spectrum.
    Skupski DW; Duzyj CM; Scholl J; Perez-Delboy A; Ruhstaller K; Plante LA; Hart LA; Palomares KTS; Ajemian B; Rosen T; Kinzler WL; Ananth C;
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):465-473. PubMed ID: 34725869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal Sonographic Diagnosis and Clinical Significance of Placenta Previa Accreta after Cesarean Section.
    Liu ZZ; Wei Y; Wang RJ; Xu W; Shi ZM; Dai Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):693-698. PubMed ID: 29125114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.